Cargando…
Brincidofovir (CMX001) for the Treatment of Severe Adenoviral Pneumonia in Kidney Transplant Recipient
Adenovirus causes significant morbidity and mortality in solid organ and hematological transplant recipients. Treatment of adenovirus infections includes supportive care, reduction of immune suppression, and in patients with severe disease, intravenous cidofovir. Brincidofovir (CMX001) is a lipid co...
Autores principales: | Sudhindra, Praveen, Knoll, Bettina, Nog, Rajat, Singh, Nandita, Dhand, Abhay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768614/ https://www.ncbi.nlm.nih.gov/pubmed/31579636 http://dx.doi.org/10.7759/cureus.5296 |
Ejemplares similares
-
Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus
por: Parker, Scott, et al.
Publicado: (2014) -
Development of CMX001 for the Treatment of Poxvirus Infections
por: Lanier, Randall, et al.
Publicado: (2010) -
Adenoviral Infections in Bone Marrow Transplanted Adult Patients: A Review of the 44 Cases Reported in the Last 25 Years
por: Keramari, Stergiani, et al.
Publicado: (2021) -
Re-establishing the utility of tetracycline-class antibiotics for current challenges with antibiotic resistance
por: LaPlante, Kerry L., et al.
Publicado: (2022) -
Disseminated Paracoccidioidomycosis in a Kidney Transplant Recipient
por: Felipe, Carlos Rafael A, et al.
Publicado: (2021)